Systemic mastocytosis
Systemic mastocytosis
Also known as:SM; systemic mastocytosis; China Second Rare Disease Catalog item 75
Systemic mastocytosis is a rare blood disorder in which mast cells accumulate in bone marrow and other organs, causing flushing, itching, diarrhea, bone pain, allergic reactions, or organ damage.
Start Here
A quick guide to the next step: which department to start with, what to prepare, and what to ask.
Recurrent unexplained flushing, fainting, low blood pressure, diarrhea, abdominal pain, bone pain, pigmented rash, or anaphylaxis should be assessed by hematology and allergy/immunology.
Mast cells release histamine and other mediators. In SM, abnormal mast cells accumulate and can trigger body-wide allergy-like symptoms; severe forms can affect liver, spleen, bones, or blood counts.
Care includes trigger identification, epinephrine preparedness, H1/H2 antihistamines, leukotriene blockers, mast cell stabilizers, bone protection, and for advanced disease KIT-targeted or cytoreductive therapy.
Most adult SM is caused by acquired somatic KIT variants and is not usually inherited. Rare familial or pediatric skin-limited forms need specialist interpretation.
Symptoms cross skin, gut, neurologic, and cardiovascular systems and may be labeled allergy, IBS, anxiety, fainting, or skin disease without baseline tryptase and marrow evaluation.
This page helps patients and families organize care leads. It does not replace a clinician’s diagnosis or treatment plan. For testing, medication, referrals, emergency care, and support applications, follow qualified clinicians, medical institutions, support organizations, and official sources.
Diagnosis Path
Organized around the practical patient journey: identify clues, avoid common delays, then prepare for care.
When to Suspect It
- Recurrent flushing, itching, urticaria-like or pigmented rash, worsened by friction or temperature changes.
- Unexplained anaphylaxis, low blood pressure, or fainting triggered by stings, medicines, alcohol, exercise, or procedures.
- Chronic abdominal pain, diarrhea, reflux, nausea, bone pain, osteoporosis, or fractures.
- Persistently elevated serum tryptase or marrow showing abnormal mast cells.
Common Wrong Turns
- Treating as ordinary allergy without tryptase, KIT D816V, and marrow involvement assessment.
- Focusing only on skin while missing osteoporosis, liver, spleen, lymph nodes, blood counts, and associated hematologic neoplasm.
- No plan for anesthesia, surgery, contrast, stings, and rescue medicines.
Departments to Start With
- Hematology
- Allergy/immunology
- Dermatology
- Osteoporosis/endocrinology or gastroenterology as needed
Before the Visit
- Record flushing, fainting, diarrhea, rash, bone pain, triggers, and anaphylaxis events.
- Bring baseline and event tryptase, CBC, liver/spleen imaging, bone density, and skin or marrow pathology.
- Bring KIT D816V or other KIT testing, flow immunophenotype, and associated blood disorder evaluation.
Tests to Ask About
- Whether criteria for systemic mastocytosis are met and whether subtype is indolent, smoldering, or advanced.
- Need for baseline tryptase, KIT D816V, marrow biopsy, and CD25/CD2/CD30 expression.
- Need for bone density, liver, spleen, lymph node, GI, and associated hematologic neoplasm assessment.
Questions for the Doctor
- Do I need to carry an epinephrine autoinjector, and which triggers or medicines should I avoid?
- What premedication is needed before surgery, dental work, anesthesia, contrast, or vaccines?
- Is my subtype managed by mediator control and monitoring, or does it need targeted therapy?
Basic Information
Medical Notes
More complete medical explanations are kept here for discussion with clinicians.
Symptoms
SM symptoms come from mast cell accumulation and mediator release. Features include flushing, itching, rash, headache, palpitations, low blood pressure, fainting, nasal congestion, wheeze, abdominal pain, diarrhea, nausea, reflux, fatigue, brain fog, anxiety, and bone pain.
Triggers include stings, alcohol, temperature change, friction, exercise, infection, emotional stress, surgery, anesthesia, and certain medicines. Severe disease can cause anaphylaxis, osteoporosis and fractures, liver, spleen or lymph node involvement, ascites, or associated blood cancer.
Diagnosis
Diagnosis usually uses baseline serum tryptase, KIT variant testing, bone marrow biopsy, and abnormal mast cell immunophenotype. Skin lesions, liver, spleen, lymph nodes, bone density, and GI symptoms help subtype the condition.
Clinicians distinguish cutaneous mastocytosis, systemic mastocytosis, mast cell activation syndrome, and ordinary allergic disease. Subtyping determines whether disease is indolent, smoldering, advanced, or associated with another hematologic neoplasm.
Treatment
Basic care is identifying and avoiding personal triggers and having an emergency plan; many patients need epinephrine. Mediator symptoms may be treated with H1/H2 antihistamines, leukotriene blockers, cromolyn, proton pump inhibitors, or antidiarrheal medicines.
Osteoporosis needs bone-protective care. Advanced SM or SM with associated blood neoplasm may require KIT-pathway targeted therapy such as midostaurin or avapritinib or other hematology treatment.
Long-term Care
Follow-up tracks symptoms and triggers, anaphylaxis risk, tryptase, CBC, liver and spleen status, bone density, GI symptoms, medication adverse effects, and quality of life.
Patients should keep written emergency and peri-procedure plans and tell anesthesia, dental, emergency, and other clinicians about SM and triggering medicines.
Fertility and Family
Adult SM usually involves acquired somatic KIT variants, so relatives are not routinely screened as for inherited disease. Pregnancy, surgery, or anesthesia should be planned with hematology, allergy/immunology, and the procedural team.
When to Seek Urgent Care
Emergency care is needed for throat tightness, wheezing, low blood pressure, fainting, widespread hives with breathing trouble, severe abdominal pain or vomiting, altered consciousness, or symptoms not improving after epinephrine.
Prognosis
Indolent SM is often managed long term; advanced SM, mast cell leukemia, or SM with an associated hematologic neoplasm has a more serious outlook and needs specialist treatment.